Medable, a trial software company, is teaming up with Pluto Health, a health data provider, to streamline and expedite patient recruitment and retention processes. The collaboration’s objectives include enhancing access to clinical research and improving data quality, with a focus on long-term participant follow-up post-trial and notification of relevant future studies tailored to individual health needs. Financial details of the partnership remain undisclosed.
“Our partnership is primarily a win for patients, alongside other stakeholders, who will benefit from ongoing enhanced support. Pluto is passionate about improving patient care in communities and designing systems that deliver resources for patients to manage health needs over time, especially if they are going through a clinical trial as part of a care option. We are excited for what the future holds with Medable.”
– Dr. Joy Bhosai, Pluto Health’s CEO and Founder
Also Read: Genentech And PeptiDream Expand Peptide Collaboration To Explore Radiopharmaceuticals For Cancer
“As a fellow female physician entrepreneur, I connected instantly with Joy and respect her company’s mission. Together, our organizations will leverage advanced technologies to reduce inefficiencies from trial execution and deliver better site and patient experiences while expanding access to clinical research to more patients when they need it most. Medable looks forward to a fruitful partnership with Pluto Health to help drive more life-saving therapies to patients faster.”
– Medable CEO and co-founder Dr. Michelle Longmire
Earlier this year, Medable partnered with nonprofit organization Every Cure to support research involving repurposing existing drugs for the treatment of rare diseases. This collaboration involved Medable supplying specialized software and services to conduct global remote clinical trials for approved drugs in different therapeutic indications.
